Yes, I believe you are correct. With the side pos
Post# of 148325
From the last PR they had 40 in screening.
Quote:
CytoDyn currently has 45 patients enrolled in monotherapy with 700 mg, 29 additional patients who have switched from lower doses to the 700 mg dose and over 40 patients currently in screening to initiate 700 mg dose arm of monotherapy trial.
Also from the slide and PR and conference talk
~59 at 350mg
~91 at 525mg
~104 at 700mg with 45 at 700mg initially + 29 switched from lower dose mono + 30 switched from combo